Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Oct;52(10):2833-9.
doi: 10.1007/s10620-006-9638-7. Epub 2007 Apr 3.

Anti-inflammatory effects of pravastatin on Helicobacter pylori-induced gastritis in mice

Affiliations

Anti-inflammatory effects of pravastatin on Helicobacter pylori-induced gastritis in mice

Masanori Yamato et al. Dig Dis Sci. 2007 Oct.

Abstract

Pravastatin, an HMG-CoA reductase inhibitor, exerts anti-inflammatory effects via several mechanisms including induction of endothelial nitric oxide synthase (eNOS). We investigated the effect of pravastatin on Helicobacter pylori-induced gastritis in mice. Mice with or without H. pylori infection received intraperitoneal pravastatin daily for 1 week. Expression of eNOS mRNA and tumor necrosis factor-alpha mRNA and myeloperoxidase activity in gastric tissue was determined. Myeloperoxidase activity was reduced in a dose-dependent manner by pravastatin, with activity inhibited by 53.5 and 73.7% at doses of 0.3 and 1 mg/kg, respectively. At a dose of 1 mg/kg, pravastatin reduced the level of tumor necrosis factor-alpha mRNA by 52.7%, while it did not affect eNOS expression. Pravastatin had no effects on these inflammatory parameters in uninfected mice. Pravastatin did not affect the viability of H. pylori. In conclusion, pravastatin exerts an anti-inflammatory effect on H. pylori-induced gastritis in mice without affecting eNOS expression.

PubMed Disclaimer

Similar articles

Cited by

References

    1. N Engl J Med. 1995 Nov 16;333(20):1301-7 - PubMed
    1. Am J Pathol. 1997 Mar;150(3):971-9 - PubMed
    1. Am J Physiol Gastrointest Liver Physiol. 2004 Oct;287(4):G919-28 - PubMed
    1. JAMA. 1998 May 27;279(20):1615-22 - PubMed
    1. N Engl J Med. 1996 Oct 3;335(14):1001-9 - PubMed

MeSH terms